2004-06-16
Angiotensin deficiency in mice leads to dilated cardiomyopathy
Publication
Publication
European Journal of Pharmacology , Volume 493 - Issue 1-3 p. 161- 165
To explore the role of angiotensin II, we assessed hemodynamics and cardiac function in angiotensinogen-deficient mice in comparison to wild-type animals. Left ventricular end-diastolic diameter and wall thickness were evaluated by echocardiography and systolic and diastolic left ventricular function by pressure-volume relations using a micro-conductance catheter. Compared to wild-type animals, the angiotensinogen-deficient mice were hypotensive and showed impaired systolic function. The hearts were dilated, demonstrated by echocardiography and by a right-ward shift of the pressure-volume loops, but end-diastolic pressure, isovolumic relaxation (τ) and diastolic stiffness were unchanged. Afterload, however, was reduced leading to maintained cardiac output. Although a blockade of the renin-angiotensin system via angiotensin converting enzyme inhibitors or angiotensin AT1 receptor antagonist is beneficial after cardiac failure, the absence of angiotensin peptides during the ontogenesis leads to dilated cardiomyopathy.
Additional Metadata | |
---|---|
, , , , | |
doi.org/10.1016/j.ejphar.2004.04.032, hdl.handle.net/1765/63783 | |
European Journal of Pharmacology | |
Organisation | Department of Pharmacology |
Walther, T., Steendijk, P., Westermann, D., Hohmann, C., Schulze, K., Heringer-Walther, S., … Tschöpe, C. (2004). Angiotensin deficiency in mice leads to dilated cardiomyopathy. European Journal of Pharmacology, 493(1-3), 161–165. doi:10.1016/j.ejphar.2004.04.032 |